Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 4/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6517217 | 0.84 | NAAA (0.38) | NAAAHTTCYP2C19EPHX1CYP19A1 | |
| SCHEMBL6521091 | 0.83 | CYP2C19 (0.41) | NAAAHTTCYP2C19EPHX1CYP19A1 | |
| SCHEMBL6513726 | 0.79 | NAAA (0.36) | NAAAHTTCYP2C19EPHX1CYP19A1 | |
| SCHEMBL6522368 | 0.78 | NAAA (0.42) | NAAAHTTCYP2C19EPHX1CYP19A1 | |
| SCHEMBL6519186 | 0.78 | CYP2C19 (0.39) | NAAAHTTCYP2C19EPHX1CYP19A1 | |
| SCHEMBL6523828 | 0.78 | CYP2C19 (0.39) | NAAAHTTCYP2C19EPHX1CYP19A1 | |
| SCHEMBL6522194 | 0.76 | SMN1; SMN2 (0.35) | SMN1; SMN2TET2MAPT | |
| SCHEMBL6519172 | 0.75 | NAAA (0.35) | NAAAHTTCYP2C19EPHX1CYP19A1 | |
| SCHEMBL6516075 | 0.75 | TET2 (0.38) | CYP2C19TET2GAA | |
| SCHEMBL6515193 | 0.75 | CYP19A1 (0.40) | HTTCYP19A1APOBEC3AAPOBEC3GSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | NAAA 2110/4885HTT 3273/4885CYP2C19 2771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.